Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

bioMerieux (BMXMF) Short Interest Ratio & Short Volume

bioMerieux logo
$148.25 0.00 (0.00%)
As of 08/22/2025
Compare

bioMerieux Short Interest Data

bioMerieux (BMXMF) has a short interest of 131,000 shares, representing 0.11% of the float (the number of shares available for trading by the public). This marks a 16.34% increase in short interest from the previous month. The short interest ratio (days to cover) is 1,310.0, indicating that it would take 1,310.0 days of the average trading volume of 94 shares to cover all short positions.

Current Short Interest
131,000 shares
Previous Short Interest
112,600 shares
Change Vs. Previous Month
+16.34%
Dollar Volume Sold Short
$18.89 million
Short Interest Ratio
1,310.0 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
118,360,000 shares
Short Percent of Float
0.11%
Today's Trading Volume
0 shares
Average Trading Volume
94 shares
Today's Volume Vs. Average
0%
Short Selling bioMerieux?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for bioMerieux and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BMXMF Short Interest Over Time

BMXMF Days to Cover Over Time

BMXMF Percentage of Float Shorted Over Time

bioMerieux Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2025131,000 shares $18.89 million +16.3%0.1%1310 $144.20
7/15/2025112,600 shares $16.04 million +32.6%N/A1126 $142.45
6/30/202584,900 shares $12.09 million -23.5%0.1%0 $142.45
6/15/2025111,000 shares $15.81 million -30.2%0.1%1110 $142.45
5/31/2025159,000 shares $21.35 million +1.1%0.1%1590 $134.25
5/15/2025157,300 shares $20.41 million +8.5%0.1%1573 $129.73
4/30/2025145,000 shares $19.00 million -44.2%N/A0 $131.01
4/15/2025260,000 shares $33.35 million +100.9%0.2%2600 $128.25
3/31/2025129,400 shares $16.30 million -7.0%0.1%323.5 $126.00
3/15/2025139,200 shares $17.22 million -10.0%0.1%126.5 $123.74
2/28/2025154,600 shares $18.62 million +43.2%0.1%118.9 $120.47
2/15/2025108,000 shares $12.61 million +3.6%0.1%51.4 $116.75
1/31/2025104,300 shares $12.66 million -10.2%N/A21.3 $121.35
1/15/2025116,100 shares $12.88 million -1.9%N/A50.5 $110.92
12/31/2024118,300 shares $12.56 million -19.1%N/A1183 $106.19
12/15/2024146,200 shares $15.65 million +5.2%N/A731 $107.03
11/30/2024139,000 shares $14.39 million +6.6%N/A1390 $103.56
11/15/2024130,400 shares $13.95 million +1.2%N/A1304 $107.01
10/31/2024128,800 shares $13.88 million +0.1%N/A51.5 $107.75
10/15/2024128,700 shares $14.62 million -20.2%N/A25.7 $113.61
9/30/2024161,300 shares $18.93 million -2.4%N/A1613 $117.36
9/15/2024165,200 shares $20.24 million -26.8%N/A1652 $122.50
8/31/2024225,800 shares $26.23 million -15.5%N/A2258 $116.17
8/15/2024267,100 shares $27.83 million +1.3%N/A2671 $104.20
7/31/2024263,600 shares $28.63 million -2.6%N/A2636 $108.60
7/15/2024270,500 shares $27.73 million -3.9%N/A2705 $102.50
6/30/2024281,400 shares $27.16 million +0.6%N/A2814 $96.50
6/15/2024279,700 shares $27.41 million +4.0%N/A1398.4 $97.98
5/31/2024269,000 shares $26.56 million -0.9%N/A2690 $98.75
5/15/2024271,300 shares $28.88 million 0.0%N/A1356.5 $106.45
4/30/2024271,400 shares $28.68 million -2.1%N/A2714 $105.67
4/15/2024277,300 shares $30.95 million +27.7%N/A2773 $111.60
3/31/2024217,200 shares $23.58 million -0.5%N/A0 $108.55
3/15/2024218,200 shares $23.69 million No ChangeN/A2182 $108.55
2/29/2024218,200 shares $24.74 million +0.7%N/A727.3 $113.38
2/15/2024216,700 shares $23.19 million No ChangeN/A2167 $107.00
1/15/2024214,200 shares $23.09 million -10.6%N/A1071 $107.79
12/31/2023239,700 shares $26.01 million +11.1%N/A780.9 $108.50
12/15/2023215,700 shares $23.40 million -41.5%N/A2157 $108.50
11/30/2023369,000 shares $39.25 million -0.1%N/A3690 $106.36
“Sell Nvidia before earnings” (Ad)

Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel

See Eric’s full analysis and get all 7 free trade ideas here
11/15/2023369,400 shares $38.69 million -1.2%N/A3694 $104.74
10/31/2023373,800 shares $34.86 million -1.7%N/A3738 $93.25
10/15/2023380,100 shares $36.63 million +22.4%N/A950.3 $96.38
9/30/2023310,500 shares $29.77 million +0.6%N/A3105 $95.88
9/15/2023308,800 shares $29.55 million +7.4%N/A3088 $95.69
8/31/2023287,500 shares $29.97 million +21.5%N/A31939.8 $104.25
8/15/2023236,600 shares $23.72 million -3.4%N/A2366 $100.25
7/31/2023244,900 shares $26.33 million No ChangeN/A2449 $107.53
7/15/2023244,900 shares $25.25 million +0.9%N/A2449 $103.10
6/30/2023242,700 shares $23.86 million +8.9%N/A2427 $98.33
6/15/2023222,900 shares $22.00 million +1.4%N/A2229 $98.70
5/31/2023219,800 shares $23.96 million No ChangeN/A2198 $109.00
5/15/2023219,800 shares $22.86 million +0.6%N/A2198 $104.00
4/30/2023218,400 shares $22.71 million -0.1%N/A2184 $104.00
4/15/2023218,700 shares $23.73 million -7.1%N/A2187 $108.50
3/31/2023235,400 shares $25.07 million +10.8%N/A2354 $106.50
3/15/2023212,500 shares $20.72 million No ChangeN/A2125 $97.50
2/28/2023212,500 shares $21.07 million No ChangeN/A2125 $99.15
2/15/2023212,500 shares $21.70 million -0.8%N/A2125 $102.13
1/31/2023214,100 shares $21.70 million -0.2%N/A2141 $101.38
1/15/2023214,600 shares $23.28 million -3.2%N/A2146 $108.50
12/30/2022221,600 shares $23.49 million No ChangeN/A1108 $106.00
12/15/2022221,600 shares $23.53 million No ChangeN/A1108 $106.18
11/30/2022221,600 shares $21.78 million -0.4%N/A2216 $98.30
11/15/2022222,500 shares $23.04 million -0.6%N/A2225 $103.53
10/31/2022223,800 shares $19.92 million +31.1%N/A746 $89.00
10/15/2022170,700 shares $13.97 million -5.4%N/A426.8 $81.85
9/30/2022180,400 shares $14.14 million No ChangeN/A1804 $78.36
9/15/2022180,400 shares $16.03 million -45.4%N/A360.8 $88.88
8/31/2022330,400 shares $30.36 million -22.1%N/A3304 $91.90
8/15/2022424,300 shares $45.67 million +12.7%N/A4243 $107.64
7/31/2022376,500 shares $40.24 million +22.9%N/A3765 $106.87
7/15/2022306,400 shares $31.33 million +3.6%N/A3064 $102.25
6/30/2022295,700 shares $27.92 million +67.2%N/A1478.5 $94.43
6/15/2022176,900 shares $15.44 million +0.6%N/A884.5 $87.30
5/31/2022175,800 shares $18.52 million No ChangeN/A879 $105.32
5/15/2022175,800 shares $16.09 million -0.6%N/A586 $91.50
4/30/2022176,800 shares $16.80 million +2.6%N/A1768 $95.00
4/15/2022172,400 shares $17.67 million -7.8%N/A1724 $102.50
3/31/2022187,000 shares $20.34 million -50.6%N/A374 $108.76
3/15/2022378,300 shares $37.89 million -21.8%N/A1261 $100.15
2/28/2022483,600 shares $52.64 million +1.8%N/A690.9 $108.85
2/15/2022475,000 shares $56.00 million +2.2%N/A678.6 $117.90
1/31/2022464,700 shares $54.62 million -11.6%N/A2323.5 $117.54
1/15/2022525,500 shares $63.06 million -10.8%N/A2627.5 $120.00
12/31/2021589,000 shares $82.46 million +5.2%N/A2945 $140.00
12/15/2021560,100 shares $77.55 million -2.5%N/A1867 $138.45
11/30/2021574,600 shares $83.32 million -2.9%N/A2873 $145.00
11/15/2021591,600 shares $74.52 million +6.0%N/A845.1 $125.96
10/29/2021558,100 shares $69.66 million +11.6%N/A5581 $124.82
“Sell Nvidia before earnings” (Ad)

Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel

See Eric’s full analysis and get all 7 free trade ideas here
10/15/2021500,100 shares $58.14 million +13.2%N/A714.4 $116.25
9/30/2021441,900 shares $50.42 million +2.4%N/A2209.5 $114.10
9/15/2021431,400 shares $56.64 million -8.5%N/A4314 $131.30
8/31/2021471,400 shares $58.76 million +0.4%N/A4714 $124.65
8/13/2021469,600 shares $54.57 million -6.8%N/A4696 $116.20
7/30/2021504,000 shares $60.78 million -13.6%N/A2520 $120.59
7/15/2021583,200 shares $62.69 million -6.1%N/A5832 $107.50
6/30/2021621,000 shares $73.15 million +0.0%N/A6210 $117.80
6/15/2021620,800 shares $71.02 million +2.8%N/A6208 $114.40
5/28/2021603,700 shares $70.63 million -0.1%N/A6037 $117.00
5/14/2021604,100 shares $68.09 million +23.3%N/A6041 $112.72
4/30/2021489,900 shares $58.91 million +19.9%N/A2449.5 $120.25
4/15/2021408,600 shares $56.01 million -3.3%N/A4086 $137.09
3/31/2021422,400 shares $51.96 million -3.4%N/A4224 $123.00
3/15/2021437,200 shares $55.50 million +1.1%N/A2186 $126.95
2/26/2021432,600 shares $55.39 million +219.7%N/A2163 $128.05
2/12/2021135,300 shares $20.47 million +47.7%N/A338.3 $151.26
1/29/202191,600 shares $14.23 million -6.6%N/A305.3 $155.38
1/15/202181,300 shares $11.40 million -1.0%N/A116.1 $140.26
12/31/202092,100 shares $13.18 million +13.3%N/A230.3 $143.15
12/15/202081,300 shares $11.87 million -1.0%N/A116.1 $146.00
11/30/202082,100 shares $11.20 million -21.1%N/A410.5 $136.43
11/15/2020104,000 shares $15.12 million +23.8%N/A173.3 $145.35
10/30/202084,000 shares $12.70 million -6.7%N/A420 $151.15
10/15/202090,000 shares $15.06 million -10.0%N/A225 $167.30
9/30/2020100,000 shares $15.50 million -3.9%N/A1000 $155.00
9/15/2020104,000 shares $15.43 million -8.9%N/A346.7 $148.33
8/31/2020114,200 shares $17.03 million +6.9%N/A285.5 $149.15

BMXMF Short Interest - Frequently Asked Questions

What is bioMerieux's current short interest?

Short interest is the volume of bioMerieux shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 131,000 shares of BMXMF short. 0.11% of bioMerieux's shares are currently sold short. Learn More on bioMerieux's current short interest.

What is a good short interest ratio for bioMerieux?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMXMF shares currently have a short interest ratio of 1,310.0. Learn More on bioMerieux's short interest ratio.

What is a good short interest percentage for bioMerieux?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of bioMerieux's floating shares are currently sold short.

Is bioMerieux's short interest increasing or decreasing?

bioMerieux saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 131,000 shares, an increase of 16.3% from the previous total of 112,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does bioMerieux's short interest compare to its competitors?

0.11% of bioMerieux's shares are currently sold short. Here is how the short interest of companies in the industry of "medical services" compare to bioMerieux: Elevance Health, Inc. (1.26%), Cencora, Inc. (3.53%), Labcorp Holdings Inc. (3.32%), Natera, Inc. (3.07%), Eurofins Scient (0.03%), Icon Plc (2.70%), Medpace Holdings, Inc. (11.01%), Solventum Corporation (2.72%), CochLear Ltd. Unsponsored ADR (0.00%), Viatris Inc. (3.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short bioMerieux stock?

Short selling BMXMF is an investing strategy that aims to generate trading profit from bioMerieux as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against bioMerieux?

A short squeeze for bioMerieux occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMXMF, which in turn drives the price of the stock up even further.

How often is bioMerieux's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMXMF, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (OTCMKTS:BMXMF) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners
Nations are at war over what’s in this box
A resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...
Behind the Markets | Sponsoredtc pixel
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsoredtc pixel
Trump’s “new dollar” could shock Americans
"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...
Stansberry Research | Sponsoredtc pixel
Here's the last trade you should make before heading out for the weekend tomorrow.
On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...
Timothy Sykes | Sponsoredtc pixel
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsoredtc pixel
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
An MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...
True Market Insiders | Sponsoredtc pixel
The New Way Retirees Are Getting Paid Extra Every Month
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel